Roger Strair
Overview
Explore the profile of Roger Strair including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
26
Citations
524
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Cooper D, Manago J, Patel V, Schaar D, Tyno A, Lin Y, et al.
Leuk Res
. 2022 Sep;
122:106934.
PMID: 36084368
Background: The excellent results of posttransplant cyclophosphamide in decreasing graft-versus-host disease (GVHD) after haploidentical (HI) allogeneic transplant have challenged current donor selection algorithms. Patients And Methods: We compared outcomes after...
2.
Percival M, Wang H, Zhang M, Saber W, de Lima M, Litzow M, et al.
Bone Marrow Transplant
. 2021 May;
56(9):2319.
PMID: 34017072
No abstract available.
3.
Percival M, Wang H, Zhang M, Saber W, de Lima M, Litzow M, et al.
Bone Marrow Transplant
. 2021 Apr;
56(9):2108-2117.
PMID: 33864019
Acute myeloid leukemia (AML) patients often undergo allogeneic hematopoietic cell transplantation (alloHCT) in first complete remission (CR). We examined the effect of depth of clinical response, including incomplete count recovery...
4.
Cooper D, Strair R
N Engl J Med
. 2021 Apr;
384(14):1374-1375.
PMID: 33826827
No abstract available.
5.
Cooper D, Manago J, Patel V, Schaar D, Krimmel T, McGrath M, et al.
Bone Marrow Transplant
. 2020 Dec;
56(5):1099-1105.
PMID: 33257777
The addition of posttransplant cyclophosphamide (PTCy) to standard graft-versus-host disease (GVHD) prophylaxis following haploidentical blood stem transplants has resulted in relatively low rates of GVHD. As GVHD remains a major...
6.
Im A, Rashidi A, Wang T, Hemmer M, MacMillan M, Pidala J, et al.
Biol Blood Marrow Transplant
. 2020 May;
26(8):1459-1468.
PMID: 32434056
Post-transplant cyclophosphamide (PTCy) has significantly increased the successful use of haploidentical donors with a relatively low incidence of graft-versus-host disease (GVHD). Given its increasing use, we sought to determine risk...
7.
Yazbeck V, Shafer D, Perkins E, Coppola D, Sokol L, Richards K, et al.
Clin Lymphoma Myeloma Leuk
. 2018 Aug;
18(9):569-575.e1.
PMID: 30122201
Background: The proteasome inhibitor bortezomib has demonstrated marked preclinical activity when combined with the histone deacetylase inhibitor vorinostat in leukemia, multiple myeloma, and mantle cell lymphoma (MCL) cells. The present...
8.
Sedhom R, Strair R, Carson J
Biol Blood Marrow Transplant
. 2018 Mar;
24(5):884-886.
PMID: 29551447
No abstract available.
9.
Strair R
J Clin Ethics
. 2017 Sep;
28(3):247-249.
PMID: 28930713
In this article I argue that the biological processes that make us human have error rates that distribute illness on a no-fault basis. I propose this as an ethical foundation...
10.
Kanate A, DiGilio A, Ahn K, Al Malki M, Jacobsen E, Steinberg A, et al.
Br J Haematol
. 2017 Aug;
182(6):916-920.
PMID: 28771676
No abstract available.